We refer the investor presentation submitted through letter dated 29th July 2022. Please note that there was a minor error in the graphical presentation of the information in slide 11 (titled North America: Respiratory, Complex generics & Peptide pipeline). In the slide the status of progress of Complex inhalation asset was erroneously shown as ''Approved'' instead of the actual status as ''Filed''. We are enclosing the updated presentation.